课题基金 / 基金详情

The molecular mechanisms regulating oncogenic signalling by sphingosine kinase 1 phosphorylation and localisation

The molecular mechanisms regulating oncogenic signalling by sphingosine kinase 1 phosphorylation and localisation
通过鞘氨醇激酶 1 磷酸化和定位调节致癌信号的分子机制
批准号:
nhmrc : 453512
负责人:
Prof Stuart Pitson
金额:
$31.02万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31

项目摘要

项目成果

Prof Stuart Pitson的其他基金

相似基金

相关文献

中文摘要
翻译
鞘氨醇激酶是一种产生脂质信号分子鞘氨醇磷酸的酶,其参与多种重要哺乳动物细胞功能的调节。研究发现,鞘氨醇激酶参与增强细胞的生长和存活。鞘氨醇激酶的失调与肿瘤发生有关,如果其活性可以被阻断,肿瘤的大小可以减小。因此,这为癌症的治疗干预提供了潜在的靶点。然而,细胞调节鞘氨醇激酶的方式并不清楚。已知鞘氨醇激酶的磷酸化增加该酶的活性,并且还引起其在质膜上的定位的移动。我们已经发现,这两个过程是必不可少的鞘氨醇激酶的致瘤作用,但很少有人知道这些过程是如何在细胞中实现的。本研究将探讨这一问题,认为了解这些过程将有助于开发新的药物来阻断鞘氨醇激酶的致瘤作用。
英文摘要
Sphingosine kinase is an enzyme that produces the lipid signalling molecule, sphingosine phosphate that is involved in the regulation of a diverse array of important mammalian cellular functions. Studies have found that sphingosine kinase is involved in enhancing the growth and survival of cells. Disregulation of sphingosine kinase is involved in tumorigenesis, and if its activity can be blocked, tumor size can be reduced. Therefore, this provides a potential target for therapeutic intervention in cancer. However, the manner by which cells regulate sphingosine kinase is not well known. It is known that phosphorylation of sphingosine kinase increases the activity of this enzyme, and also causes a shift in its localisation the the plasma membrane. We have found that both of these processes are essential for the tumorigenic effects of sphingosine kinase, but very little is known about how these processes are achieved in the cell. This study will investigate this problem with the view that understanding these processes will assist in the development of new drugs to block the tumorigenic effects of sphingosine kinase.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting sphingolipid metabolism in disease
  • 批准号:
    nhmrc : GNT1156693
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $64.92万
  • 财政年份:
    2019
  • 负责人:
    Prof Stuart Pitson
  • 依托单位:
Defining the role of a palmitoylated variant of sphingosine kinase 1 in cancer
  • 批准号:
    nhmrc : 1084772
  • 项目类别:
    Project Grants
  • 资助金额:
    $40.24万
  • 财政年份:
    2015
  • 负责人:
    Prof Stuart Pitson
  • 依托单位:
Sphingosine kinase as a target for anti-cancer therapy
  • 批准号:
    nhmrc : GNT1042589
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $59.08万
  • 财政年份:
    2013
  • 负责人:
    Prof Stuart Pitson
  • 依托单位:
Sphingosine kinase as a target for anti-cancer therapy
  • 批准号:
    nhmrc : 1042589
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $50.1万
  • 财政年份:
    2013
  • 负责人:
    Prof Stuart Pitson
  • 依托单位:
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位: